一心堂(002727.SZ):擬收購紅瑞樂邦所持有18家門店資產及其存貨
格隆匯 12 月 24日丨一心堂(002727.SZ)公佈,根據公司的業務定位及發展規劃,公司全資子公司貴州鴻翔一心堂醫藥連鎖有限公司(“貴州一心堂”)擬以不超過3800萬元收購貴州紅瑞樂邦醫藥連鎖有限公司(“紅瑞樂邦”)所持有18家門店資產及其存貨,其中3100萬元用於支付門店轉讓費及購買其附屬資產(不含存貨)、不超過700萬元用於購買門店庫存商品(所屬實物資產及存貨部分根據雙方實際盤點結算)。該項購買以自有資金支付。
公司2020年第16次總裁辦公會討論決定同意公司全資子公司貴州一心堂收購紅瑞樂邦所持有18家門店資產及其存貨。
此次交易的審批在總裁權限範圍內,無需提交董事會審議批准。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.